Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Bioventus Inc. - Class A Common Stock (NQ:BVS)

7.450 -0.030 (-0.40%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 7, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 439,677
Open 7.510
Bid (Size) 6.290 (100)
Ask (Size) 9.590 (2,000)
Prev. Close 7.480
Today's Range 7.260 - 7.570
52wk Range 5.810 - 12.61
Shares Outstanding 10
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
These stocks are gapping in today's session
Investors and traders are closely monitoring the gap up and gap down stocks in today's session on Tuesday. Let's explore the market movements and identify the stocks with significant gaps. 
Via Chartmill
Bioventus Inc (NASDAQ:BVS) Reports Q3 2025 Earnings Beat and Strong Profitability Growth
Bioventus (BVS) reported strong Q3 2025 earnings, beating EPS estimates with a 200% surge. While revenue slightly missed, organic growth was up 8.2%. 
Via Chartmill
Topics Earnings

Performance

YTD
-29.9%
-29.9%
1 Month
+13.1%
+13.1%
3 Month
+7.5%
+7.5%
6 Month
+10.5%
+10.5%
1 Year
-37.0%
-37.0%

More News

Read More
Bioventus Reports Third Quarter Financial Results
From Bioventus, Inc.
Via GlobeNewswire
Earnings Scheduled For November 4, 2025
Via Benzinga
Bioventus to Report Third Quarter of Fiscal Year 2025 Financial Results on November 4, 2025
From Bioventus, Inc.
Via GlobeNewswire
Earnings Scheduled For August 6, 2025
Via Benzinga
Earnings Scheduled For May 6, 2025
Via Benzinga
Halper Sadeh LLC Encourages Bioventus Inc. Shareholders to Contact the Firm to Discuss Their Rights
From Halper Sadeh LLC
Via Business Wire
Bioventus to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference
From Bioventus, Inc.
Via GlobeNewswire
Bioventus to Present at the Canaccord Genuity 45th Annual Global Growth Conference
From Bioventus, Inc.
Via GlobeNewswire
Examining the Future: Bioventus's Earnings Outlook
Via Benzinga
Bioventus Inc. (NASDAQ:BVS) Reports Mixed Q2 2025 Earnings Amid Muted Market Reaction
Via Chartmill
Bioventus Reports Second Quarter Financial Results
From Bioventus, Inc.
Via GlobeNewswire
Bioventus Enters into a New $400 Million Senior Secured Credit Agreement Lowering Interest Expense and Providing Increased Liquidity
From Bioventus, Inc.
Via GlobeNewswire
Bioventus Receives FDA 510(k) Clearances for two Next-Generation Peripheral Nerve Stimulation Products
From Bioventus, Inc.
Via GlobeNewswire
Bioventus to Report Second Quarter of Fiscal Year 2025 Financial Results on August 6, 2025
From Bioventus, Inc.
Via GlobeNewswire
Bioventus Reports First Quarter Financial Results
From Bioventus, Inc.
Via GlobeNewswire
Bioventus to Report First Quarter of Fiscal Year 2025 Financial Results on May 6, 2025
From Bioventus, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Gapping stocks in Tuesday's session
Via Chartmill
Medical Device Firm Bioventus Stock Jumps On Upbeat 2025 Outlook, Cuts Debt By $48 Million
Via Benzinga
Stay updated with the stocks that are on the move in today's pre-market session.
Via Chartmill
Korn Ferry Posts Better-Than-Expected Earnings, Joins Bioventus, Endeavour Silver, Vail Resorts And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
Bioventus Announces Fourth Quarter and Full Year 2024 Financial Results
From Bioventus, Inc.
Via GlobeNewswire
Earnings Scheduled For March 11, 2025
Via Benzinga

Frequently Asked Questions

Is Bioventus Inc. - Class A Common Stock publicly traded?
Yes, Bioventus Inc. - Class A Common Stock is publicly traded.
What exchange does Bioventus Inc. - Class A Common Stock trade on?
Bioventus Inc. - Class A Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Bioventus Inc. - Class A Common Stock?
The ticker symbol for Bioventus Inc. - Class A Common Stock is BVS on the Nasdaq Stock Market
What is the current price of Bioventus Inc. - Class A Common Stock?
The current price of Bioventus Inc. - Class A Common Stock is 7.450
When was Bioventus Inc. - Class A Common Stock last traded?
The last trade of Bioventus Inc. - Class A Common Stock was at 11/07/25 04:00 PM ET
What is the market capitalization of Bioventus Inc. - Class A Common Stock?
The market capitalization of Bioventus Inc. - Class A Common Stock is 74.50
How many shares of Bioventus Inc. - Class A Common Stock are outstanding?
Bioventus Inc. - Class A Common Stock has 74 shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.